Within one month, the bodyweight of mice in the low, medium and high BCM-7 treated groups increased slightly with an increasing dose of BCM-7 (1.31%, 1.99%, 2.24%), the bodyweight of Aged control mice and young mice increased by 1.22% and 6.63%, respectively (Fig 1A). The results show that BCM-7 contributes to body weight gain after aging, thisperhaps due to BCM-7 being easily digested and absorbed by the body and enhancing pepsin activity
(Asledottir et al., 2019). Around one month. The bodyweight of the Aged control group was significantly lower than that of the young mice (-14.56%), (Fig 1B) and the bodyweight of the mice in the low, medium and high BCM-7 intervention groups were also lower than that of the Aged control group and the degree of weight loss was similar to the intervention dose of BCM-7 (-0.98%, -1.02%, -1.21%), the decrease in body weight with aging may be related to the weakening of the metabolic rate after body aging and the reduction of muscle mass, which are all features of body aging, but the rate of weight gain was greatly influenced by the concentration of BCM-7, too high BCM-7 concentration is not conducive to maintaining a healthy weight in mice. The renal index of the aged control mice increased slightly and the spleen index decreased marginally (Fig 1C and 1D) compared with young mice, those maybe because 11-month-old mice only show reproductive aging and have not reached the state of complete aging
(Schneider et al., 2017). The medium-dose BCM-7 intervention lead to a dramatic reduction in the spleen index of aging mice (-33.57%, Fig 1D) compared with the aged control mice, indicating that BCM-7 may cause atrophy and dysfunction of immune organs.
We found that the content of Cys-C (Fig 2A) was significantly increased in the aging control group compared with the young mice (+13.11%), showing that aging may cause the decrease of glomerular filtration rate in mice, increase the natural aging of the body (
Wasén et al., 2003), The ACTH content of aging mice decreases with the increase of the BCM-7 intervention dose, especially the difference between ACTH content in the middle and high BCM-7 intervention groups with young group mice were dramatic (-35.50%; -44.68%), showing that excessive BCM-7 may actively cause endocrine disorders (Fig 2B). The quality of endocrine function affects the body’s hormone levels, development and aging are related to changes in endocrine function in the life cycle. Various diseases caused by age will lead to the decline of hormone negative feedback regulation function and the weakening of cognitive function
(Kudielka et al., 2004). There was no evident concentration dependence between Cys-C content of aging mice and BCM-7 intervention dose, the small change range indicated that Cys-C was not affected by the dose of BCM-7. The Cys-C content of middle-dose mice was significantly reduced (-11.11%) compared with the aged control group
(Juraschek et al., 2013). Cys-c can be completely filtered by the glomerulus and then absorbed and degraded by the renal tubular cells. Cys-c is not easily affected by inflammation, body muscle mass, diet, body mass, renal tubular secretion. Based on these characteristics, Cys-c is currently an endogenous markerof glomerular filtration rate that is better than creatinine and urea nitrogen
(Gompou et al., 2015). CK is one of the key enzymes in energy metabolism. The CK (Fig 2C) content of the aged control group was slightly lower than that of the young blank group (-7.43%), Some studies have found that the CK content is negatively correlated with age
(Neidert et al., 2015), which may be affected by the skeletal muscle content of the aging body. Decreased skeletal muscle will lead to insufficient creatine kinase; it is difficult to provide the body’s average energy needs, forcing creatine phosphate to generate creatinine through irreversible non-enzymatic channels. If the glomeruli are damaged, creatinine will not be filtered from the glomeruli. A large amount of enrichment produces toxicity, so creatine kinase and creatinine are closely related and creatine kinase can be used as a marker for early diagnosis of renal function (
Ueda and Sakasegawa 2016). The latest research shows that a 4-week high-protein diet can reduce body fat and increase skeletal muscle mass
(Ato et al., 2020).
As is shown in Fig 3, we observed the swelling of individual renal tubular epithelium and the degeneration of renal tubular epithelium in low-dose aging mice. Middle-dose aging mice showed noticeable renal tubular epithelial turbidity and vacuolar degeneration. The renal tubular cortex and epithelial cells of the high-dose aging mice were swollen, the epithelium was slightly vacuolated, the interstitial cells were infiltrated by the inflammatory cells and the individual renal tubular epithelial cells were shed, a small amount of protein cast was seen. The cortical structure of the mice in the aging control group was clear and a small number of lymphocytes were scattered and infiltrated in the renal cortical interstitium. In the young control group, the cortical structure was clear, the number of nephrons was normal and there was no degeneration, swelling, or inflammation of tubular epithelial cells. Whereas, there was slight vacuolation in the renal cortical tubular epithelium.
In the final experiment, the results show that the sIgA content of the aged control mice was significantly increased compared with the young mice (+126.09%). The sIgA content of the BCM-7 group mice were proportional to the BCM-7 intervention dose (Fig 4A), the results found that the low dose BCM-7 can dramatically reduce the sIgA content ofaging mice (-58.08%), indicating that aging causes the mice humoral immunity to strengthen and low dose BCM-7 can effectively reverse this trend. However, the production levels of pro-inflammatory and anti-inflammatory factors vary abnormally (Fig 4B; 4C). To compared with young mice, the levels of IL-1β, IL-6, IL-13 and TGF-β1 all decreased in the aged control mice, especially the levels of IL-6 and TGF-β1 were significantly lower than those of young mice (-25.20%; -32.72%), only TNF-a level in the aged control group was slightly higher than that in young mice. In the BCM-7 intervention group, IL-1β levels were proportional to the BCM-7 dose, TNF-a and TGF-β1 levels were inversely proportional to the BCM-7 dose (Fig 4C). The middle-dose group BCM-7 can significantly increase the levels of IL-6 and IL-13 in aging mice compared with the low-dose group (+37.29%; +98.41%), high-dose BCM-7 can significantly increase IL-1β in aging mice compared with aged control mice (+46.40%). Finally, we observed changes in the level of inflammation marker CRP (Fig 4D), The CRP level of aged control group mice was slightly lower than that of young mice and the CRP level of mice in the BCM-7 intervention group showed an increasing trend with the rise of the BCM-7 intervention dose, the high-dose BCM-7 can significantly increase the CRP level of aging mice compared with the aged control group (+71.55%). These results show us that inflammatory cells infiltrate in the aging mouse combined with the pathological section of kidney tissue in this experiment.
To repel harmful stimuli and restore the body to a healthy state, the immune system will cause a series of pathological manifestations such as tissue damage
(Mazzaferro et al., 2020). The body’s aging process is accompanied by dysregulation of cytokines and changes in the quality and quantity of the immune system, This process is called immune aging
(Alvarez-Rodriguez et al., 2012). Plasma CRP is moderately elevated and can be used to predict mortality (
Iannitti and Palmieri 2011). After taking an equal gradient concentration of BCM-7 to gavage the aging mouse, as the intervention dose increases, BCM-7 can Significantly induce kidney inflammation and gradually increase kidney damage
(Huang et al., 2008), physiological aging and immune aging occur almost simultaneously. We observed that the changes between pro-inflammatory and anti-inflammatory factors were disordered and that the mice showed dysregulation of cytokines under the dual influence of BCM-7 and aging. For the inflammatory marker CRP, the experimental result further indicates that the intervention of BCM-7 can trigger inflammatory stress in aging mice and the degree of stress is proportional to the concentration of BCM-7 intervention.